Skip to main content

Advertisement

Log in

Body mass index and lung cancer risk: results from the ICARE study, a large, population-based case–control study

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Background

The association between body mass index (BMI) and lung cancer is still disputed because of possible residual confounding by smoking and preclinical weight loss in case–control studies. We examined this association using data from the multicenter ICARE study in France, a large, population-based case–control study.

Methods

A total of 2,625 incident lung cancer cases and 3,381 controls were included. Weight was collected at interview, 2 years before the interview, and at age 30. Lifetime smoking exposure was calculated using the comprehensive smoking index (CSI). Adjusted odds ratios (aORs) and 95 % confidence intervals were estimated by unconditional logistic regression and controlled for age, area, education, CSI, occupational exposure, previous chronic bronchitis, and parental history of lung cancer. We also examined the role of weight change. Analyses were stratified by smoking status and sex.

Results

When compared with that of men with normal BMI 2 years before the interview, lung cancer aORs (95 % CI) among men with BMIs of <18.5, 25–29.9, 30–32.4, and ≥32.5 kg/m² were 2.7 (95 % CI 1.2–6.2), 0.9 (95 % CI 0.7–1.1), 0.8 (95 % CI 0.6–1.1), and 0.8 (95 % CI 0.6–1.0), respectively (p trend = 0.02). Results were more pronounced among current smokers and were similar in men and women. Weight gain over time was associated with a significant decreased risk of lung cancer.

Conclusions

We found an inverse dose-dependent association between lung cancer risk and BMI 2 years prior to interview in current smokers.

Impact statement

BMI might be an individual factor impacting the risk of lung cancer related to smoking’s carcinogen-induced DNA damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Notes

  1. France is divided into 96 administrative units called départements.

References

  1. WHO (2008) GLOBOCAN. Cancer incidence and mortality worldwide in 2008. http://globocan.iarc.fr/

  2. Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117(2):294–299

    Article  PubMed  CAS  Google Scholar 

  3. Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. Chest 132(3 Suppl):29S–55S

    Article  PubMed  CAS  Google Scholar 

  4. Koshiol J, Rotunno M, Consonni D, Pesatori AC, De Matteis S, Goldstein AM et al (2009) Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One 4(10):e7380

    Article  PubMed  Google Scholar 

  5. Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC et al (2009) Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 4(3):291–299

    Article  PubMed  Google Scholar 

  6. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD (2005) Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60(7):570–575

    Article  PubMed  CAS  Google Scholar 

  7. Alavanja MC, Brownson RC, Boice JD Jr, Hock E (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 136(6):623–632

    PubMed  CAS  Google Scholar 

  8. Rodriguez-Roisin R, Soriano JB (2008) Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease. Proc Am Thorac Soc 5(8):842–847

    Article  PubMed  Google Scholar 

  9. Tyczynski JE, Bray F, Parkin DM (2003) Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 4(1):45–55

    Article  PubMed  Google Scholar 

  10. Brenner AV, Wang Z, Kleinerman RA, Wang L, Zhang S, Metayer C et al (2001) Previous pulmonary diseases and risk of lung cancer in Gansu Province, China. Int J Epidemiol 30(1):118–124

    Article  PubMed  CAS  Google Scholar 

  11. Pairon JC, Brochard P, Le Bourgeois JP, Ruffié P (eds) (2000) Les cancers professionnels. Editions Margaux Orange, Paris, France

    Google Scholar 

  12. WHO/FAO (2003) Diet, nutrition and the prevention of chronic disease. In: WHO technical reports series 916. Report of a Joint WHO/FAO Expert Consultation, Geneva

  13. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591

    Article  PubMed  CAS  Google Scholar 

  14. Ursin G, Longnecker MP, Haile RW, Greenland S (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6(2):137–141

    Article  PubMed  CAS  Google Scholar 

  15. Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G et al (2008) Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 122(7):1604–1610

    Article  PubMed  CAS  Google Scholar 

  16. Kabat GC, Chang CJ, Wynder EL (1994) The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 23(6):1137–1144

    Article  PubMed  CAS  Google Scholar 

  17. Franceschi S, Dal Maso L, Levi F, Conti E, Talamini R, La Vecchia C (2001) Leanness as early marker of cancer of the oral cavity and pharynx. Ann Oncol 12(3):331–336

    Article  PubMed  CAS  Google Scholar 

  18. Andreotti G, Hou L, Beane Freeman LE, Mahajan R, Koutros S, Coble J et al (2010) Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. Cancer Causes Control 21(11):1759–1775

    Article  PubMed  Google Scholar 

  19. Chyou PH, Nomura AM, Stemmermann GN (1994) A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers. Int J Cancer 57(3):313–317

    Article  PubMed  CAS  Google Scholar 

  20. Drinkard CR, Sellers TA, Potter JD, Zheng W, Bostick RM, Nelson CL et al (1995) Association of body mass index and body fat distribution with risk of lung cancer in older women. Am J Epidemiol 142(6):600–607

    PubMed  CAS  Google Scholar 

  21. Goodman MT, Wilkens LR (1993) Relation of body size and the risk of lung cancer. Nutr Cancer 20(2):179–186

    Article  PubMed  CAS  Google Scholar 

  22. Kabat GC, Kim M, Hunt JR, Chlebowski RT, Rohan TE (2008) Body mass index and waist circumference in relation to lung cancer risk in the women’s health initiative. Am J Epidemiol 168(2):158–169

    Article  PubMed  Google Scholar 

  23. Kabat GC, Miller AB, Rohan TE (2007) Body mass index and lung cancer risk in women. Epidemiology 18(5):607–612

    Article  PubMed  Google Scholar 

  24. Kabat GC, Wynder EL (1992) Body mass index and lung cancer risk. Am J Epidemiol 135(7):769–774

    PubMed  CAS  Google Scholar 

  25. Kanashiki M, Sairenchi T, Saito Y, Ishikawa H, Satoh H, Sekizawa K (2005) Body mass index and lung cancer: a case-control study of subjects participating in a mass-screening program. Chest 128(3):1490–1496

    Article  PubMed  Google Scholar 

  26. Kark JD, Yaari S, Rasooly I, Goldbourt U (1995) Are lean smokers at increased risk of lung cancer? The Israel Civil Servant Cancer Study. Arch Intern Med 155(22):2409–2416

    Article  PubMed  CAS  Google Scholar 

  27. Knekt P, Heliovaara M, Rissanen A, Aromaa A, Seppanen R, Teppo L et al (1991) Leanness and lung-cancer risk. Int J Cancer 49(2):208–213

    Article  PubMed  CAS  Google Scholar 

  28. Koh WP, Yuan JM, Wang R, Lee HP, Yu MC (2010) Body mass index and smoking-related lung cancer risk in the Singapore Chinese Health Study. Br J Cancer 102(3):610–614

    Article  PubMed  Google Scholar 

  29. Kollarova H, Machova L, Horakova D, Cizek L, Janoutova G, Janout V (2008) Is obesity a preventive factor for lung cancer? Neoplasma 55(1):71–73

    PubMed  CAS  Google Scholar 

  30. Kubik A, Zatloukal P, Boyle P, Robertson C, Gandini S, Tomasek L et al (2001) A case-control study of lung cancer among Czech women. Lung Cancer 31(2–3):111–122

    Article  PubMed  CAS  Google Scholar 

  31. Kubik AK, Zatloukal P, Tomasek L, Pauk N, Havel L, Krepela E et al (2004) Dietary habits and lung cancer risk among non-smoking women. Eur J Cancer Prev 13(6):471–480

    Article  PubMed  CAS  Google Scholar 

  32. Olson JE, Yang P, Schmitz K, Vierkant RA, Cerhan JR, Sellers TA (2002) Differential association of body mass index and fat distribution with three major histologic types of lung cancer: evidence from a cohort of older women. Am J Epidemiol 156(7):606–615

    Article  PubMed  CAS  Google Scholar 

  33. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6(11):863–873

    PubMed  CAS  Google Scholar 

  34. Rauscher GH, Mayne ST, Janerich DT (2000) Relation between body mass index and lung cancer risk in men and women never and former smokers. Am J Epidemiol 152(6):506–513

    Article  PubMed  CAS  Google Scholar 

  35. Chiolero A, Faeh D, Paccaud F, Cornuz J (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87(4):801–809

    PubMed  CAS  Google Scholar 

  36. Hamilton W, Peters TJ, Round A, Sharp D (2005) What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax 60(12):1059–1065

    Article  PubMed  CAS  Google Scholar 

  37. Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR et al (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46

    Article  PubMed  CAS  Google Scholar 

  38. Buccheri G, Ferrigno D (2004) Lung cancer: clinical presentation and specialist referral time. Eur Respir J 24(6):898–904

    Article  PubMed  CAS  Google Scholar 

  39. Corner J, Hopkinson J, Fitzsimmons D, Barclay S, Muers M (2005) Is late diagnosis of lung cancer inevitable? Interview study of patients’ recollections of symptoms before diagnosis. Thorax 60(4):314–319

    Article  PubMed  CAS  Google Scholar 

  40. Luce D, Stucker I (2011) Investigation of occupational and environmental causes of respiratory cancers (ICARE): a multicenter, population-based case-control study in France. BMC Public Health 11:928

    Article  PubMed  Google Scholar 

  41. WHO (World Health Organization) (2000) International classification of diseases for oncology, 3rd edn. WHO, Geneva

    Google Scholar 

  42. Rothman KJ, Greenland S (2008) Modern epidemiology, 3rd edn. Lippincott Williams and Wilkins, Philadelphia

    Google Scholar 

  43. WHO-IARC (2007) IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol 90. WHO-IARC, Lyon, France

    Google Scholar 

  44. WHO-IARC (2012) IARC monographs on the evaluation of carcinogenic risks to humans. Chemical agents and related occupations, vol 100. WHO-IARC, Lyon, France

  45. Consonni D, De Matteis S, Lubin JH, Wacholder S, Tucker M, Pesatori AC et al (2010) Lung cancer and occupation in a population-based case-control study. Am J Epidemiol 171(3):323–333

    Article  PubMed  Google Scholar 

  46. Ahrens W, Merletti F (1998) A standard tool for the analysis of occupational lung cancer in epidemiologic studies. Int J Occup Environ Health 4(4):236–240

    PubMed  CAS  Google Scholar 

  47. WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO technical report series 894. World Health Organization, Geneva

  48. WHO Global database on body mass index. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html

  49. Leffondre K, Abrahamowicz M, Xiao Y, Siemiatycki J (2006) Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat Med 25(24):4132–4146

    Article  PubMed  Google Scholar 

  50. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E et al (2011) COPD in never-smokers: results from the population-based burden of obstructive lung disease study. Chest 139(4):752–763

    Google Scholar 

  51. Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370(9589):765–773

    Article  PubMed  Google Scholar 

  52. Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA et al (2006) A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 107(4):781–792

    Article  PubMed  Google Scholar 

  53. Stommel M, Schoenborn CA (2009) Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES and NHIS 2001–2006. BMC Public Health 9:421

    Article  PubMed  Google Scholar 

  54. Unité de surveillance et d’épidémiologie nutritionnelle (Usen) (2007) Étude nationale nutrition santé (ENNS 2006)—situation nutritionnelle en France en 2006 selon les indicateurs d’objectif et les repères du Programme national nutrition santé (PNNS). Institut de veille sanitaire, Université de Paris 13, Conservatoire national des arts et métiers

  55. Ichiba M, Yamada S, Ishii K, Gonda K, Murai R, Shimomura T et al (2007) Significance of urinary excretion of 8-hydroxy-2′-deoxyguanosine in healthy subjects and liver disease patients. Hepatogastroenterology 54(78):1736–1740

    PubMed  CAS  Google Scholar 

  56. Kasai H, Iwamoto-Tanaka N, Miyamoto T, Kawanami K, Kawanami S, Kido R et al (2001) Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: effects of exercise, working conditions, meat intake, body mass index, and smoking. Jpn J Cancer Res 92(1):9–15

    Article  PubMed  CAS  Google Scholar 

  57. Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE (1992) Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 13(12):2241–2247

    Article  PubMed  CAS  Google Scholar 

  58. Mizoue T, Kasai H, Kubo T, Tokunaga S (2006) Leanness, smoking, and enhanced oxidative DNA damage. Cancer Epidemiol Biomarkers Prev 15(3):582–585

    Article  PubMed  CAS  Google Scholar 

  59. Pilger A, Germadnik D, Riedel K, Meger-Kossien I, Scherer G, Rudiger HW (2001) Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults. Free Radic Res 35(3):273–280

    Article  PubMed  CAS  Google Scholar 

  60. Pilger A, Rudiger HW (2006) 8-hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health 80(1):1–15

    Article  PubMed  CAS  Google Scholar 

  61. Sakano N, Wang DH, Takahashi N, Wang B, Sauriasari R, Kanbara S et al (2009) Oxidative stress biomarkers and lifestyles in Japanese healthy people. J Clin Biochem Nutr 44(2):185–195

    Article  PubMed  CAS  Google Scholar 

  62. Tamae K, Kawai K, Yamasaki S, Kawanami K, Ikeda M, Takahashi K et al (2009) Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine. Cancer Sci 100(4):715–721

    Article  PubMed  CAS  Google Scholar 

  63. Yano T, Shoji F, Baba H, Koga T, Shiraishi T, Orita H et al (2009) Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients. Lung Cancer 63(1):111–114

    Article  PubMed  Google Scholar 

  64. Godschalk RW, Feldker DE, Borm PJ, Wouters EF, van Schooten FJ (2002) Body mass index modulates aromatic DNA adduct levels and their persistence in smokers. Cancer Epidemiol Biomarkers Prev 11(8):790–793

    PubMed  CAS  Google Scholar 

  65. Palli D, Vineis P, Russo A, Berrino F, Krogh V, Masala G et al (2000) Diet, metabolic polymorphisms and DNA adducts: the EPIC-Italy cross-sectional study. Int J Cancer 87(3):444–451

    Article  PubMed  CAS  Google Scholar 

  66. Rundle A, Madsen A, Orjuela M, Mooney L, Tang D, Kim M et al (2007) The association between benzo[a]pyrene-DNA adducts and body mass index, calorie intake and physical activity. Biomarkers 12(2):123–132

    Article  PubMed  CAS  Google Scholar 

  67. Peluso M, Airoldi L, Munnia A, Colombi A, Veglia F, Autrup H et al (2008) Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European prospective investigation into cancer and nutrition (EPIC) prospective study. Br J Nutr 100(3):489–495

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank American Journal Experts for their editorial assistance. This work was supported by the French agency of health security (ANSES); the Fondation de France; the French National Research Agency (ANR); the National Institute of Cancer (INCA); the Foundation for Medical Research (FRM); The French Institute for Public Health Surveillance (InVS); The Health Ministry (DGS); the Organization for the Research on Cancer (ARC); and the French Ministry of work, solidarity and public function (DGT).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabelle Stücker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tarnaud, C., Guida, F., Papadopoulos, A. et al. Body mass index and lung cancer risk: results from the ICARE study, a large, population-based case–control study. Cancer Causes Control 23, 1113–1126 (2012). https://doi.org/10.1007/s10552-012-9980-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-012-9980-3

Keywords

Navigation